| dc.contributor.author | Perretti, M | en_US |
| dc.contributor.author | Godson, C | en_US |
| dc.date.accessioned | 2021-11-02T13:38:26Z | |
| dc.date.available | 2020-07-10 | en_US |
| dc.date.issued | 2020-10 | en_US |
| dc.identifier.issn | 0007-1188 | en_US |
| dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/74934 | |
| dc.format.extent | 4595 - 4600 | en_US |
| dc.relation.ispartof | BRITISH JOURNAL OF PHARMACOLOGY | en_US |
| dc.rights | This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. | |
| dc.subject | annexin A1 | en_US |
| dc.subject | GPCRs | en_US |
| dc.subject | lipoxins | en_US |
| dc.subject | small molecule agonists | en_US |
| dc.subject | therapeutic innovation | en_US |
| dc.title | Formyl peptide receptor type 2 agonists to kick-start resolution pharmacology | en_US |
| dc.type | Article | |
| dc.rights.holder | © 2020 The Authors. British Journal of Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society | |
| dc.identifier.doi | 10.1111/bph.15212 | en_US |
| pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000571019900001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
| pubs.issue | 20 | en_US |
| pubs.notes | Not known | en_US |
| pubs.publication-status | Published | en_US |
| pubs.volume | 177 | en_US |
| rioxxterms.funder | Default funder | en_US |
| rioxxterms.identifier.project | Default project | en_US |
| qmul.funder | The patho-physiology of the ALX receptor in inflammation::Wellcome Trust | en_US |
